Does Medicare Cover Zepbound? Eligibility and Coverage Basics

Wondering if you qualify for Medicare coverage? Talk with a DevotedDOc healthcare provider.

For many people considering prescription weight management treatment, one of the first questions is: Does Medicare cover Zepbound? As of July 1, 2026, Medicare provides coverage for certain forms of Zepbound through the Medicare GLP-1 Bridge Program for beneficiaries who meet specific coverage and clinical requirements.

However, Medicare coverage for Zepbound is not automatic. You must have qualifying Medicare drug coverage, meet the program’s body mass index (BMI) and health criteria, and receive a prescription from a healthcare provider. Prior authorization may also be required before the pharmacy can process the medication.

The program currently covers only the Zepbound KwikPen. It does not cover Zepbound single-dose pens or single-dose vials. Eligible beneficiaries pay a flat $50 copayment for a one-month supply through the Bridge Program.

Understanding the broader rules for Medicare GLP-1 coverage can help you determine whether Zepbound or another covered medication may be available based on your health history and prescription drug coverage.

Does Medicare Cover Zepbound?

Yes, Medicare covers Zepbound for certain eligible beneficiaries through the Medicare GLP-1 Bridge Program. The program began on July 1, 2026, and is available nationwide, including all U.S. states and territories.

Medicare coverage under this program is limited to the Zepbound KwikPen formulation. The program does not cover Zepbound single-dose pens or vials. Therefore, having a prescription for Zepbound does not necessarily mean that the specific formulation prescribed will qualify for Bridge coverage.

To qualify, you must have Medicare drug coverage through an eligible Part D arrangement, such as:

• A standalone Medicare prescription drug plan
• A Medicare Advantage plan that includes drug coverage
• A Medicare Special Needs Plan
• An employer or union group waiver plan
• The Limited Income Newly Eligible Transition program

You must also meet the program’s clinical eligibility requirements. Medicare does not provide this coverage to every beneficiary who wants to use Zepbound for weight management.

What Is the Medicare GLP-1 Bridge Program?

The Medicare GLP-1 Bridge is a temporary CMS demonstration program designed to expand access to certain prescription weight management medications. It currently operates from July 1, 2026, through December 31, 2027.

The covered medications include:

• Zepbound KwikPen
• Wegovy injections and tablets
• Foundayo tablets

The program operates separately from the normal Part D payment process. Although beneficiaries must have Medicare drug coverage to qualify, medications filled through the Bridge Program are not processed as ordinary Part D claims.

Eligible beneficiaries pay $50 for a one-month supply. That copayment remains the same regardless of the beneficiary’s current Part D coverage phase.

You can review the full Medicare GLP-1 eligibility requirements to better understand how the Bridge Program works and which health conditions may qualify.

Who Is Eligible for Medicare Coverage for Zepbound?

Zepbound Medicare eligibility depends on age, Medicare drug coverage, BMI, qualifying health conditions, and how the medication is being prescribed.

You must be at least 18 years old, have qualifying Medicare Part D coverage, and meet one of the following clinical pathways when beginning GLP-1 treatment.

A BMI of 35 or Higher

You may qualify if your BMI is 35 or higher. Under this pathway, Medicare does not require an additional qualifying medical condition beyond meeting the BMI requirement.

Your healthcare provider must still determine whether Zepbound is medically appropriate and prescribe it as part of a weight management plan.

A BMI of 30 or Higher With a Qualifying Condition

You may qualify with a BMI of 30 or higher if you also have at least one of the following conditions:

• Heart failure with preserved ejection fraction, sometimes called diastolic heart failure
• Uncontrolled high blood pressure
• Chronic kidney disease at stage 3a or higher

Your provider will need to document your BMI and qualifying diagnosis as part of the coverage process.

A BMI of 27 or Higher With a Qualifying Condition

You may also qualify with a BMI of 27 or higher if you have at least one of these conditions:

• Prediabetes
• A previous heart attack
• A previous stroke
• Symptomatic peripheral artery disease affecting the arms or legs

Meeting one of these criteria does not guarantee that Zepbound is appropriate for you. Your healthcare provider must evaluate your medical history, current medications, treatment goals, and possible safety concerns before prescribing it.

Zepbound is a once-weekly tirzepatide injection used with a reduced-calorie diet and increased physical activity. It may help adults with obesity, or certain adults with overweight and a weight-related medical condition, lose excess body weight and maintain weight reduction.

Who Is Not Eligible for Medicare Coverage for Zepbound?

Although the Medicare GLP-1 Bridge Program expands access to weight loss medications, not everyone with Medicare qualifies. Some beneficiaries are excluded because Medicare already considers their prescription eligible under the standard Part D benefit instead of the Bridge Program.

You are generally not eligible for the Medicare GLP-1 Bridge Program if you:

• Already receive a GLP-1 medication through your Medicare Part D plan.
• Have type 2 diabetes.
• Have moderate to severe obstructive sleep apnea.
• Have noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis.

For these conditions, Medicare expects beneficiaries to obtain GLP-1 medications through their regular Part D prescription drug coverage rather than through the Bridge Program. Even if your Part D plan does not currently cover a GLP-1 medication for one of these conditions, CMS states that you are still not eligible for Bridge Program coverage. Instead, you would follow your Part D plan’s existing coverage and appeal process. (CMS)

In addition, CMS reviews whether a beneficiary has already received certain GLP-1 medications through Medicare Part D. If you previously received a covered GLP-1 through your Part D plan, that history may affect your eligibility for the Bridge Program.

Does Medicare Pay for Zepbound Through Part D?

The answer depends on why Zepbound is prescribed.

If your healthcare provider prescribes Zepbound solely for chronic weight management and you meet the Bridge Program requirements, Medicare coverage is generally provided through the Medicare GLP-1 Bridge Program rather than your standard Part D benefit.

However, if your healthcare provider prescribes Zepbound for an FDA-approved indication that Medicare Part D already covers, your Part D plan should process the prescription instead of the Bridge Program.

For example, CMS explains that beneficiaries prescribed Zepbound for moderate to severe obstructive sleep apnea in adults with obesity should receive coverage through their Medicare Part D plan because that indication is already eligible under the standard Part D benefit.

Similarly, the Bridge Program specifically supports chronic weight management. It does not replace existing Medicare Part D coverage for other FDA-approved medical conditions.

Because coverage pathways differ based on the reason for treatment, your healthcare provider and pharmacy determine whether to submit your prescription through the Medicare GLP-1 Bridge Program or your regular Medicare Part D plan.

Does Zepbound Require Prior Authorization?

Yes. In many cases, prescription coverage for Zepbound requires prior authorization before the medication can be dispensed.

As part of the Medicare GLP-1 Bridge Program, your healthcare provider may need to submit documentation confirming that you meet the clinical eligibility requirements. This includes verifying that:

• You meet the required BMI criteria.
• You have any qualifying medical conditions, if applicable.
• Zepbound is being prescribed for chronic weight management.
• You are participating in a lifestyle program that includes diet and physical activity.

Once approved, the prior authorization generally remains valid through December 31, 2027, including dose increases and refills, unless you switch to a different GLP-1 medication. (Medicare.gov)

If you’d like to learn more about the approval process, our guide to GLP-1 prior authorization explains what information insurers typically require and how healthcare providers submit these requests.

How Much Does Zepbound Cost With Medicare?

Eligible beneficiaries enrolled in the Medicare GLP-1 Bridge Program pay a $50 copayment for a one-month supply of Zepbound.

Unlike medications processed through the standard Part D benefit, this copayment:

• Does not count toward your annual Part D deductible.
• Does not count toward your Part D out-of-pocket spending limit.
• Does not appear on your Part D Explanation of Benefits.
• Cannot be reduced through the Extra Help program.
• Cannot be spread over multiple months using the Medicare Prescription Payment Plan.

The $50 monthly copayment remains the same regardless of which phase of your Medicare Part D coverage you are currently in. Additional healthcare costs, such as office visits or laboratory testing, may still apply depending on your medical needs and insurance coverage.

Frequently Asked Questions

Get Help Determining Your Medicare Eligibility

If you’re wondering whether you qualify for Medicare coverage for Zepbound, a healthcare provider can review your BMI, medical history, current Medicare prescription coverage, and treatment goals to determine the most appropriate option.

At DevotedDOc, we help patients understand their coverage options, evaluate eligibility for GLP-1 medications, and complete the necessary documentation when prior authorization is required. Whether you’re interested in starting Zepbound or exploring other prescription weight management options, our team can guide you through each step of the process.

Learn more about our medical weight loss program or schedule an evaluation for online Zepbound treatment to discuss your eligibility and weight management goals with a healthcare provider.